期刊文献+

乙胺丁醇体外诱导结核分枝杆菌耐药性的实验研究 被引量:2

Drug resistance of Mycobacterium tuberculosis induced by ethambutol in vitro
下载PDF
导出
摘要 目的研究乙胺丁醇(EMB)体外诱导结核分枝杆菌耐药性,指导临床合理用药。方法对结核分枝杆菌H_(37)Rv实施乙胺丁醇耐药性诱导试验,对诱导菌侏和34株耐药临床分离株进行聚合酶链反应-单链构象多态性(PCR-SSCP)和测序分析(DS)。结果 12株耐药临床分离株和第8代H_(37)Rv诱导株的PCR-SSCP出现异常电泳图谱,DS证实发生embB306 ATG→GTG突变。结论长期间歇低浓度药物刺激能够诱导结核分枝杆菌获得性耐EMB。 Objective To study the drug resistance of Mycobacterium tuberculosis induced by ethambutol in vitro, and to guide the selection and use of anti-tuberculous agents in clinical practice. Methods The induced experiments of drug resistance on Mycobacterium tuberculosis H37Rv by ethambutol in vitro were performed. The induced strains and 34 ethambutol-resistant strains were analyzed by polymerase chain reaction-single stranded conformation polymorphism (PCR-SSCP) and PCR-direct sequencing (PCR-DS) techniques. Results The SSCP spectrum in 12 ethambutol-resistant strains and the induced strains of eighth generation was different from that of wild type H37Rv. PCR-DS showed the mutation from ATG to GTG at codon 306 of embB. Conclusion The acquired ethambutol-resistance could be induced by long term exposure to the low level of intermittent antibacterial agents.
机构地区 解放军第
出处 《中华老年多器官疾病杂志》 2011年第2期104-106,共3页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 分枝杆菌 结核 乙胺丁醇 抗药性 细菌 Mycobacterium tuberculosis ethambutol drug resistance, bacterial
  • 相关文献

参考文献9

  • 1吴雪琼,张俊仙,刘佳文,黄海南,王晋洪.PCR-SSCP分支杆菌菌种初步鉴定方法的建立及其应用[J].中国现代医学杂志,2000,10(7):25-26. 被引量:46
  • 2中困防痨协会.《结核病诊断实验室检验规程》[M].北京:中国教育文化出版社,2006:8-45.
  • 3刘贵建,许淑珍,马纪平,张淑兰.多步法抗菌药物诱导性肠球菌耐药的实验研究[J].中华医院感染学杂志,2005,15(6):601-604. 被引量:17
  • 4陈妍,罗予,毛理纳.氟喹诺酮类药物体外诱导肺炎克雷伯菌耐药后GyrA和ParC的变异[J].中国微生态学杂志,2009,21(2):145-148. 被引量:11
  • 5Starks AM, Gumusboga A, Plikaytis BB, et al.Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis[J]. Antirnicrob Agents Chemother, 2009, 53(3): 1061-1066.
  • 6Srivastava S, Ayyagari A, Dhole TN, et al. emb nucleofide polymorphisms and the role of embB306 mutations in Mycobacteriurn tuberculosis resistance to ethambutol[J], Int J Med Microbiol, 2009, 299(4): 269-280.
  • 7Ramaswamy S, Amin AG, Goksel S, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobactedum tuberculosis[J]. Antimicrob Agents Chemother, 2000, 44(2): 326-336.
  • 8Jaber AA, Ahmad S, Mokaddas E. Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait[J]. Ann Clin Mierobiol Antimicrob, 2009, 8(1): 2.
  • 9Jadaun GP, Das R, Upadhyay P, et al. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuber- culosis isolates from India[J].Int J Antimicrob Agents, 2009, 33(5): 483-486.

二级参考文献16

  • 1邓晓慧,孙爱慧,陈苏婉,张守钗,刘小康.氟喹诺酮类药物对肺炎克雷伯杆菌体外防耐药突变浓度的研究[J].四川生理科学杂志,2007,29(3):104-106. 被引量:3
  • 2高山,普珍,孙晓明,刘小康.肺炎克雷伯杆菌对氟喹诺酮类抗生素耐药机制的研究[J].华西药学杂志,2006,21(1):21-24. 被引量:13
  • 3叶晓光,韩菊梅.体外氟喹诺酮类诱导肺炎克雷伯菌耐药与临床分离耐药株QRDR变异的差异研究[J].中华医院感染学杂志,2006,16(12):1321-1324. 被引量:9
  • 4Clinical and Labortory Standards Institute (CLSI/NCCLS). Performance Standards for Antimicrobial Susceptibility Testing;Sixteenth Informational Supplement[S]. 2006. M100-S16.
  • 5BRISSE S, VERHOEF J. Phylogenetic diversity of Klebsiella pneumoniae and KlebsieUa oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping[ J]. Int J Syst Evol Microbiol,2001,51 (Pt3) :915-924.
  • 6HOOPER D C. New uses for new and old quinolones and the challenge of resistance[J]. Clin Infect Dis,2000,30(2) :243-254.
  • 7DASHTI A A,PATON R,AMYES S G. Linkage of ciprofloxacin Pneumoniae [ J]. Int J Antimicrob Agents,2006,27 ( 1 ) :73-76.
  • 8Tankovic J, Mahjoubi F, Courvalin P, et al. Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene[J]. Antimicrob Agents Chemother, 1996,40(11):2558-2561.
  • 9Amin EL, Jalal S,Wretlind B. Alterations in gyrA and parC associated with fluoroquinolones resistance in Enterococcus faecium[J]. Antimicrob Agents Chemother, 1999, 43(4): 947-949.
  • 10Rybkine T, Mainardi JL, Sougakoff W, et al. Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of β-lactam resistance[J]. J Infect Dis, 1998,178:159-163.

共引文献70

同被引文献23

  • 1李洪敏,吴雪琼,王巍,梁建琴,张滔,李燕峰.结核杆菌embB基因突变与临床治疗的关系[J].军医进修学院学报,2004,25(3):219-221. 被引量:2
  • 2刘贵建,许淑珍,马纪平,张淑兰.多步法抗菌药物诱导性肠球菌耐药的实验研究[J].中华医院感染学杂志,2005,15(6):601-604. 被引量:17
  • 3李亮,唐俊舫,端木宏谨,郑素华,刘宇红.我国老年结核病流行现状分析[J].中华医学杂志,2006,86(37):2646-2648. 被引量:30
  • 4Yew WW, Leung CC. Update in tuberculosis 2008. Am J Respir Crit Care Med, 2009,179 : 337-343.
  • 5Cox H, MeDermid C. XDR tuberculosis can be cured with aggressive treatment. Lancet, 2008,372: 1363-1365.
  • 6Garcia de Viedma D, del Sol Diaz Infantes M, Lasala F, et al. New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol, 2002,40: 988-995.
  • 7Ramaswamy SV, Amin AG, Goksel S, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2000, 44: 326- 336.
  • 8Rizvi N,Shah H, Inayat N, et al. Differences in clinical presentation of pulmonary tuberculosis in association with age[J]. J Pak Med Assoc, 2003,53 : 321-323.
  • 9Towhidi M, Azarian A, Asnaashari A. Pulmonary tuberculosis in the elderly[J]. Tanaffos, 2008,7 .. 52- 57.
  • 10Castaigne G, Tondeur M, de Wit S, et al. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated lover of unknown origina retrospective study[J]. Nucl Med Commun, 2009,30 : 41-47.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部